Phathom Pharmaceuticals Inc Conference call on the PHALCON-EE Trial Results Transcript
Ladies and gentlemen, thank you for standing by, and welcome to Phathom Pharmaceuticals Phase III PHALCON-EE top line trial results conference call. (Operator Instructions)
I would now like to hand the call over to Joe Hand. Thank you. Please go ahead, sir.
Good morning, and thank you for joining us. My name is Joe Hand, and I'm Phathom's Chief Administrative Officer. We're excited to discuss the results from our PHALCON-EE Phase III erosive esophagitis trial that we shared earlier and to answer questions you have regarding the data. At the end of today's presentation, we will hold a Q&A session with Terrie Curran, our President and Chief Executive Officer; Azmi Nabulsi, our Chief Operating Officer; Martin Gilligan, our Chief Commercial Officer; and Tom Harris, our Senior Vice President, Regulatory Affairs.
As a reminder, matters covered in today's presentation, including the accompanying slides, include forward-looking statements. Such statements involve risks and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
